45 related articles for article (PubMed ID: 25778843)
1. The Antitumor Effect of Gekko Sulfated Glycopeptide by Inhibiting bFGF-Induced Lymphangiogenesis.
Ding XL; Man YN; Hao J; Zhu CH; Liu C; Yang X; Wu XZ
Biomed Res Int; 2016; 2016():7396392. PubMed ID: 27190997
[TBL] [Abstract][Full Text] [Related]
2. Thermochemotherapy effect of nanosized As2O3/Fe3O4 complex on experimental mouse tumors and its influence on the expression of CD44v6, VEGF-C and MMP-9.
Du Y; Zhang D; Liu H; Lai R
BMC Biotechnol; 2009 Oct; 9():84. PubMed ID: 19804631
[TBL] [Abstract][Full Text] [Related]
3. Angiogenesis and lymphangiogenesis as prognostic factors after therapy in patients with cervical cancer.
Biedka M; Makarewicz R; Kopczyńska E; Marszałek A; Goralewska A; Kardymowicz H
Contemp Oncol (Pozn); 2012; 16(1):6-11. PubMed ID: 23788848
[TBL] [Abstract][Full Text] [Related]
4. Mathematical modeling of Interleukin-35 promoting tumor growth and angiogenesis.
Liao KL; Bai XF; Friedman A
PLoS One; 2014; 9(10):e110126. PubMed ID: 25356878
[TBL] [Abstract][Full Text] [Related]
5. Decoding the synergistic potential of MAZ-51 and zingerone as therapy for melanoma treatment in alignment with sustainable development goals.
Letsoalo K; Nortje E; Patrick S; Nyakudya T; Hlophe Y
Cell Biochem Funct; 2024 Mar; 42(2):e3950. PubMed ID: 38348768
[TBL] [Abstract][Full Text] [Related]
6. Expression of LASS2 Can be Regulated by Dihydroartemisinin to Regulate Cisplatin Chemosensitivity in Bladder Cancer Cells.
Qiao X; Xue R; Li S; Li J; Ji C
Curr Pharm Biotechnol; 2024 May; ():. PubMed ID: 38757331
[TBL] [Abstract][Full Text] [Related]
7. Interplay of precision therapeutics and MD study: Calocybe indica's potentials against cervical cancer and its interaction with VEGF via octadecanoic acid.
Datta S; Verma P; Dhara B; Kundu R; Maitra S; Mitra AK; Khan MS; Zughaibi TA; Tabrez S; Kumer A
J Cell Mol Med; 2024 Apr; 28(8):e18302. PubMed ID: 38652115
[TBL] [Abstract][Full Text] [Related]
8. Retraction Note: IL-1RA inhibits esophageal carcinogenesis and lymphangiogenesis via downregulating VEGF-C and MMP9.
Shen Z; Zhang P; Zhang W; Luo F; Xu H; Chen S; Kang M
Funct Integr Genomics; 2024 May; 24(3):89. PubMed ID: 38730124
[No Abstract] [Full Text] [Related]
9. Mechanistic basis of a combination D-penicillamine and platinum drugs synergistically inhibits tumor growth in oxaliplatin-resistant human cervical cancer cells in vitro and in vivo.
Chen SJ; Kuo CC; Pan HY; Tsou TC; Yeh SC; Chang JY
Biochem Pharmacol; 2015 May; 95(1):28-37. PubMed ID: 25801007
[TBL] [Abstract][Full Text] [Related]
10. Full-Length Semaphorin-3C Is an Inhibitor of Tumor Lymphangiogenesis and Metastasis.
Mumblat Y; Kessler O; Ilan N; Neufeld G
Cancer Res; 2015 Jun; 75(11):2177-86. PubMed ID: 25808871
[TBL] [Abstract][Full Text] [Related]
11. Homodimeric peptide radiotracer [
Chen X; Zhang Z; Wang L; Zhang J; Zhao T; Cai J; Dang Y; Guo R; Liu R; Zhou Y; Wei R; Lou X; Xia F; Ma D; Li F; Dai J; Li F; Xi L
Eur J Nucl Med Mol Imaging; 2024 Feb; ():. PubMed ID: 38411667
[TBL] [Abstract][Full Text] [Related]
12. Role of Cytokines and Chemokines in Angiogenesis in a Tumor Context.
Geindreau M; Bruchard M; Vegran F
Cancers (Basel); 2022 May; 14(10):. PubMed ID: 35626056
[TBL] [Abstract][Full Text] [Related]
13. Insights into the Mechanisms of Action of MDA-7/IL-24: A Ubiquitous Cancer-Suppressing Protein.
Modi J; Roy A; Pradhan AK; Kumar A; Talukdar S; Bhoopathi P; Maji S; Mannangatti P; Sanchez De La Rosa D; Li J; Guo C; Subler MA; Windle JJ; Cavenee WK; Sarkar D; Wang XY; Das SK; Emdad L; Fisher PB
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008495
[TBL] [Abstract][Full Text] [Related]
14. Targeting angiogenesis in myocardial infarction: Novel therapeutics (Review).
Li J; Zhao Y; Zhu W
Exp Ther Med; 2022 Jan; 23(1):64. PubMed ID: 34934435
[TBL] [Abstract][Full Text] [Related]
15. Corneal Lymphangiogenesis: Current Pathophysiological Understandings and Its Functional Role in Ocular Surface Disease.
Lee HK; Lee SM; Lee DI
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769057
[TBL] [Abstract][Full Text] [Related]
16. CD59 receptor targeted delivery of miRNA-1284 and cisplatin-loaded liposomes for effective therapeutic efficacy against cervical cancer cells.
Wang L; Liang TT
AMB Express; 2020 Mar; 10(1):54. PubMed ID: 32185543
[TBL] [Abstract][Full Text] [Related]
17. Cisplatin inhibits the growth, migration and invasion of cervical cancer cells by down-regulating IL-17E/IL-17RB.
Cheng J; Gu CJ; Zhang B; Xie F; Yuan MM; Li MQ; Yu JJ
Int J Clin Exp Pathol; 2017; 10(9):9341-9351. PubMed ID: 31966806
[TBL] [Abstract][Full Text] [Related]
18. Effect of TALEN-mediated IL-6 knockout on cell proliferation, apoptosis, invasion and anti-cancer therapy in hepatocellular carcinoma (HCC-LM3) cells.
Zhuang PY; Zhang KW; Wang JD; Zhou XP; Liu YB; Quan ZW; Shen J
Oncotarget; 2017 Sep; 8(44):77915-77927. PubMed ID: 29100435
[TBL] [Abstract][Full Text] [Related]
19. Combination of IL-24 and cisplatin inhibits angiogenesis and lymphangiogenesis of cervical cancer xenografts in a nude mouse model by inhibiting VEGF, VEGF-C and PDGF-B.
Wang Z; Lv J; Zhang T
Oncol Rep; 2015 May; 33(5):2468-76. PubMed ID: 25778843
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
